A Study of the Effectiveness and Clinical Practice Use of Glecaprevir/Pibrentasvir in Adolescents With Chronic Hepatitis C Genotypes 1 to 6 in Russian Federation
Clinical trial NCT04189627 · COMPLETED
Trial details
- NCT number
- NCT04189627
- Sponsor
- AbbVie
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2020-02-17
- Primary completion
- 2021-06-24
- Enrollment
- 99
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.